Empagliflozin Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats by Modulating Sesn2/AMPK/Nrf2 Signaling and Targeting Ferroptosis and Autophagy

(2023). Empagliflozin Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats by Modulating Sesn2/AMPK/Nrf2 Signaling and Targeting Ferroptosis and Autophagy. Egyptian Society of Diabetes and Lipidology Journal, 3(1), -. doi: 10.21608/esdlj.2023.456170

. "Empagliflozin Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats by Modulating Sesn2/AMPK/Nrf2 Signaling and Targeting Ferroptosis and Autophagy", Egyptian Society of Diabetes and Lipidology Journal, 3, 1, 2023, -. doi: 10.21608/esdlj.2023.456170

(2023). 'Empagliflozin Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats by Modulating Sesn2/AMPK/Nrf2 Signaling and Targeting Ferroptosis and Autophagy', Egyptian Society of Diabetes and Lipidology Journal, 3(1), pp. -. doi: 10.21608/esdlj.2023.456170

Empagliflozin Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats by Modulating Sesn2/AMPK/Nrf2 Signaling and Targeting Ferroptosis and Autophagy. Egyptian Society of Diabetes and Lipidology Journal, 2023; 3(1): -. doi: 10.21608/esdlj.2023.456170